I en dyremodel for familiær adenomatøs polyposis (FAP) gav behandling med rosiglitazon i doser på 200 gange den farmakologiske aktive dosis anledning til forøget tumormangfoldighed i colon.
23 In an animal model for familial adenomatous polyposis (FAP), treatment with rosiglitazone at 200 times the pharmacologically active dose increased tumour multiplicity in the colon.